AtheroNova Inc. announced earnings results for the year-ended December 31, 2013. For the year, the company reported net loss attributable to holders of common stock was $7.81 million or $0.20 basic and diluted loss per share against $2.64 million or $0.09 basic and diluted loss per share a year ago.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% | -.--% | -26.67% |
2016 | AtheroNova Operations, Inc. Bankruptcy Case Dismissed | CI |
2015 | First Motion for Exclusivity Period Extension Approved For AtheroNova Operations, Inc. | CI |
1st Jan change | Capi. | |
---|---|---|
-26.67% | 9.69T | |
+43.36% | 5.46TCr | |
-5.31% | 3.99TCr | |
+37.52% | 3.88TCr | |
+14.75% | 2.69TCr | |
-12.56% | 2.62TCr | |
-22.45% | 1.88TCr | |
+0.04% | 1.22TCr | |
+25.12% | 1.22TCr | |
+26.04% | 1.19TCr |
- Stock Market
- Equities
- AHROQ Stock
- News AtheroNova Inc.
- AtheroNova Inc. Announces Earnings Results for the Year-Ended December 31, 2013